P rimary percutaneous coronary intervention (PCI) is the preferred method of reperfusion for ST-segmentelevation myocardial infarction (STEMI) because it achieves higher rates of epicardial patency and myocardial perfusion compared with fibrinolysis. 1, 2 The effectiveness of PCI can be assessed by angiographic indices of epicardial and myocardial reperfusion and resolution of ST-segment elevation, each of which have been strongly correlated with clinical outcomes. 3 Regarding angiographic markers of perfusion, thrombolysis in myocardial infarction (TIMI) flow grade assesses the briskness of blood flow and washout in the infarct-related artery, 4 while densitometric Myocardial Blush Grade (MBG) evaluates the patency of the myocardial microcirculation. 5 PCI operators (Op) tend to overestimate severity of stenoses before PCI and underestimate them after the procedure, compared with the results of quantitative coronary angiography performed at an angiographic core laboratory (ACL). 6-9 Much less is known regarding the ability of operators to accurately assess markers of reperfusion. 10 Poor correlation between Op and ACL evaluation of TIMI flow and MBG may result in suboptimal procedures and outcomes, and the site-reported determination of surrogate end points for clinical trials may be inaccurate (important if an ACL is not available).
both by the Op and ACL for pre-PCI and final TIMI flow and MBG and correlated these findings with 3-year mortality.
Methods
The HORIZONS-AMI trial has been described in detail. 11 Briefly, 3602 patients with STEMI with symptom onset <12 hours in duration undergoing primary PCI were randomized in 2×2 factorial design to bivalirudin or heparin plus a glycoprotein inhibitor (1:1 assignment), and subsequently to paclitaxel-eluting or bare metal stents (3:1 assignment), in order to test 2 hypotheses: (1) Bivalirudin with a provisional glycoprotein inhibitor , compared with heparin with a glycoprotein inhibitor, will reduce the combined end point of death, reinfarction, revascularization, stroke, and major bleeding at 30 days. ( 2) The paclitaxel-eluting stent, compared with the identical bare metal stent, will reduce the rate of ischemic revascularization at 1 year. This analysis aimed to (1) assess the reliability of Op readings compared with ACL readings; and (2) compare the 2 readings for the prognostic information they offer. Clinical follow-up was performed at 30 days, 6 months, 1 year, and then yearly through 3 years. Primary and major secondary end point events (including death, reinfarction, stroke, ischemic target vessel revascularization, stent thrombosis, and bleeding) were adjudicated by a clinical events committee blinded to patient allocation and index procedure angiographic results.
Operators were asked to classify TIMI flow (scale 0 to 3) and densitometric MBG (scale 0 to 3; 0 and 1 combined) before and after the procedure, following a detailed presentation of the definitions by ACL representatives. The ACL (Cardiovascular Research Foundation) performed a similar assessment using previously validated definitions, 5, 12 with expert independent reviewers over-reading the technicians' assessments. The ACL readers were blinded to operator readings performed at the time of the procedure and to any clinical information. The present analysis comparing the level of concordance and relative prognostic value of angiographic measures as assessed by individual Op and the ACL was prespecified in the original HORIZONS-AMI study protocol. The 15 technicians (N=15) performing the ACL reading were either foreign medical doctors or had at least a bachelor of science degree. They were trained individually by the director of ACL and other senior technicians for 6 months (3 months for qualitative coronary angiography and 3 months for quantitative angiography) and underwent a standardized test before being certified to read independently.
The intergroup (Op versus ACL) agreement was assessed using Cohen's κ coefficient, which evaluates not only the agreement between the 2 determinations but also incorporates agreement that can occur by chance when readers have a limited number of categories to choose. 13, 14 If the raters are in complete agreement, κ=1. If there is no agreement among the raters other than what would be expected by chance, as defined by Pr(e), κ=0.
This parameter is considered superior to simply comparing the proportion of patients receiving a certain rating, as this measure can obscure the fact that it is not the same patient who received a certain rating by both readers. In general, κ <0 indicates no agreement, 0 to 0.20 indicates slight agreement, 0.21 to 0.40 indicates fair agreement, 0.41 to 0.60 indicates moderate agreement, 0.61 to 0.80 indicates substantial agreement, and 0.81 to 1.0 indicates almost perfect agreement. Because MBG 2 and 3 carry similar prognostic significance (representing an open microcirculation), 15 we combined these grades (with MBG 0 or 1 representing a closed microcirculation). Similarly, since the best survival occurs with pre-PCI or post-PCI TIMI 3 flow, we combined TIMI flow grades 0 to 2 to create 2 discrete prognostically relevant groups. 16 We also present the positive and negative percent agreement between the tests using the definitions (a,b,c,d represent the 4 permutations of concordance or discordance between the assessment of Op and ACL using a 2-category scale: 0 to 2 versus 3 for TIMI flow and 0 to 1 versus 2 to 3 for MBG). 17 : positive percent agreement=100%×a/(a+c) negative percent agreement=100%×d/(b+d) Multivariable models were developed to identify the independent predictive value of post-PCI TIMI flow 0 to 2 (versus 3) and MBG 0 to 1 (versus 2 to 3) on 3-year mortality. In addition to TIMI flow and MBG in their respective models, other candidate variables (based on the overall HORIZONS-AMI trial model for mortality 18 ) were: age, gender, diabetes, baseline creatinine clearance, baseline hemoglobin, baseline white blood cell (WBC), Killip Class II-IV (versus I), time from symptom onset to PCI, left anterior descending artery infarctrelated artery, and bivalirudin allocation. Each model was run first using exclusively Op data and then again with exclusively ACL data. We also evaluated the independent prognostic value of the following combinations of angiographic reperfusion according to the extent of Op and ACL concordance: for TIMI flow (Op 0 to 2/ACL 0 to 2, Op 3/ACL 0 to 2, Op 0 to 2/ACL 3 versus Op 3/ACL 3) and for MBG (Op 0 to 1/ACL 0 to 1, Op 2 to 3/ACL 0 to 1, Op 0 to 1/ACL 2 to 3 versus Op 2 to 3/ACL 2 to 3). We used a stepwise selection algorithm to select additional significant predictors with entry/leave significance levels of 0.1/0.1. Significance level was set at 0.05. All analyses were performed with SAS 9.2 (TS2M3).
Results

Patients and Operator Versus Angiographic Core Laboratory Concordance
As previously described, 19 the patients enrolled in HORIZONS-AMI were typical for STEMI studies. The median interquartile range [IQR] age was 60 [52 to 70] years, and 77% were male. Hypertension, hyperlipidemia, and diabetes mellitus were present in 52%, 43%, and 16% of patients, respectively.
After excluding patients treated medically (N=193) and those treated with delayed PCI or surgery (N=64), 3345 subjects undergoing primary PCI were eligible for this study. Matching ACL and Op angiographic data were available for 3153, 3099, 3058 and 2987 patients for pre-and post-PCI TIMI flow and MBG, respectively, representing >90% of the PCI cohort. The pre-and post-PCI TIMI flow and MBG according to Op and ACL are shown in aggregate in 
WHAT IS KNOWN
• Compared with an independent angiographic core laboratory, operators tend to overestimate severity of stenoses before PCI and underestimate them after the procedure.
• Much less is known regarding the ability of operators to accurately assess markers of reperfusion, such as TIMI flow grade and myocardial blush grade.
WHAT THE STUDY ADDS
• This is the largest comparison to date of operator and core laboratory assessment of angiographic reperfusion parameters in patients with STEMI undergoing primary PCI.
• Nearly one quarter of patients had discordant scoring between prognostically different categories of TIMI flow and densitometric myocardial blush grade. TIMI 3 or both TIMI 0 to 2) and discordant in 483 cases (15.3%; one, TIMI 3, and the other, TIMI 0 to 2), κ=0.51 (0.47 to 0.54). For post-PCI TIMI flow, Op and ACL were concordant in 2718 cases (87.1%) and discordant in 381 cases (12.9%), κ=0.35 (0.33 to 0.38). For pre-PCI MBG, Op and ACL were concordant in 2448 cases (80.1%: either both MBG 0 to 1 or both MBG 2 to 3) and discordant in 610 cases (19.9%), κ=0.41 (0.36 to 0.47). And for post-PCI MBG, Op and ACL were concordant in 2316 cases (77.6%) and discordant in 671 cases (22.4%), κ=0.20 (0.16 to 0.24). Thus, Op and ACL agreement κ pre-PCI was moderate-substantial for TIMI flow and fair-moderate for MBG, while post-PCI, it was fair for TIMI flow and slight-fair for MBG. Moreover, for each of these categories, the probability of chance agreement was substantial, varying between 0.66 and 0.80. On a vessel level, the degree of Op and ACL discordance was roughly comparable for the left anterior descending artery, left circumflex artery, and right coronary artery (Table 1 ). In general, the level of concordance between Op and ACL for both TIMI flow and MBG was better in each vessel at baseline (pre-PCI) than it was post-PCI (Table 1) .
Of note, among 415 total patients with final TIMI flow scored 0 to 2 by the ACL, Op scoring was TIMI flow 3 in 267 (64.3%). Conversely, in 2684 cases when the ACL final TIMI flow was 3, the Op score was concordant in 2570 (95.7%). Similarly, of the 706 patients with final MBG 0 to 1 by the ACL, 563 (79.7%) were classified as MBG 2 to 3 by Op. Conversely, of 2281 patients scored as MBG 2 to 3 by ACL, 2173 (95.3%) were concordant by Op. Patients for whom Op and ACL were concordant for TIMI 0 to 2 and TIMI 3 scores had the highest and lowest rates of mortality, respectively, with the discordant groups having intermediate mortality. Figure 4 displays similar results for densitometric MBG. The concordant Op and ACL readings for post-PCI MBG 0 to 1 and 2 to 3 again had the highest and lowest rates of mortality, respectively. The discordant groups (671 patients, 22.4% of the entire cohort) again had intermediate mortality. We confirmed these observations by quantifying and plotting the interaction between the adjusted hazard ratios and confidence intervals for the Op and ACL determinations on mortality ( Figure 5 for post-PCI TIMI flow, and Figure 6 for post-PCI MBG). For TIMI 3 flow, either assessment was associated with a lower hazard for death at 3 years than TIMI 0 to 2 flow (P=0.06 for both, P INT =0.71). The association between post-PCI MBG and death was more complex. Both Op (P=0.001) and ACL (P=0.03) grade 2/3 MBG were highly associated separately with lower mortality, but only A B P<0.0001, respectively). Other independent predictors of higher death rate were increasing age, higher baseline creatinine level and white blood count, anterior infarct, and treatment with heparin plus a glycoprotein inhibitor (versus bivalirudin). Table 2 shows the multivariable predictive value of combinations of Op and ACL grading for 3-year mortality, using concordant successful reperfusion (ie, Op/ACL TIMI 3 and Op/ACL MBG 2 to 3) as the reference. Concordant Op and ACL assessment of unsuccessful reperfusion by both TIMI and MBG were strongly predictive of mortality, whereas discordant assessment of reperfusion, while associated with modestly reduced survival, did not reach statistical significance except for post-PCI Op 3/ACL 0 to 2.
Predictive Value of Final TIMI and MBG Grades for 3-Year Mortality
Discussion
This is the largest comparison to date of Op versus ACL assessment of angiographic reperfusion parameters in patients with STEMI undergoing primary PCI. The principal message is that discordant scoring between prognostically different categories of TIMI flow and densitometric MBG was present in 12% to 25% of patients. After excluding random variation, given the limited number of categories from which to choose, concordance between Op and ACL for pre-PCI TIMI flow and MBG was, at best, moderate and for post-PCI TIMI flow and MBG, was at best fair. Not surprisingly, there was considerable tendency among Op to score angiographic outcomes that are less than optimal (such as final TIMI flow <3 or final MBG 0 to 1) more favorably than the ACL. In contrast, Op rarely downgraded results considered optimal by the ACL. These findings suggest that some interventions aimed at improving epicardial and myocardial reperfusion may not be deemed necessary because Op already perceive their results as optimal. 20, 21 Interestingly, 3-year mortality in discordant patients was intermediate between reperfusion judged by both Op and ACL to be either successful or unsuccessful, and the multivariable value of discordant scoring to predict mortality (or survival) was not nearly as strong as when the Op and ACL agreed. This observation suggests that some of the operator assessment, particularly when upcoding, might be based on transient or unrecorded appearance of the epicardial artery or the microcirculation and not necessarily the inability to correctly interpret the angiograms.
In the present study, there was substantial upcoding by operators of unfavorable results (>60% for both TIMI flow and MBG) while there was very little downcoding (<5% for both TIMI flow and MBG). The fact that Op tend to overestimate the severity of findings at baseline and underestimate the severity of the same measures post-treatment is a well-known phenomenon, although most previous reports on Op versus ACL assessments stem from restenosis studies. For example, Desmet et al 7 showed, in 114 patients, that operators underestimate the post-PCI residual stenosis and that the greater the residual stenosis, the more profound the degree of underestimation. The only previous study that compared Op and ACL markers of reperfusion was published from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX) trial. In 922 patients, there was moderate agreement between Op and ACL for pre-PCI TIMI flow (κ=0.56) and fair agreement for post-PCI TIMI flow (κ=0.36). 10 Directionality in disagreement was again observed, with underestimation of favorable pre-PCI findings and overestimation of favorable post-PCI results. MBG was not assessed by Op in APEX, and, thus, the present study in a larger number of patients both confirms and extends these prior results.
The discordance in MBG observed between Op and ACL in the present study is perhaps not unexpected, as assessment of densitometric MBG is nuanced and not frequently evaluated by Op. In contrast, the TIMI scale of epicardial flow has been around for decades, 4 is simpler to score, and is routinely reported by Op. Indeed, the prognostic value of TIMI flow grade in this study was comparable between Op and ACL, while only concordant MBG 0/1 was predictive of poor outcome. Whether Op and ACL discordance in angiographic reperfusion markers is a reflection of human nature, inadequate Op training, or is due to Op incorporation of the clinical status of the patient into their angiographic assessment (eg, greater propensity to score TIMI-3 flow in a patient hemodynamically stable with chest pain relief and ST-segment resolution after PCI) deserves further study.
In this regard, whether Op or ACL assessments of angiographic reperfusion provide greater prognostic accuracy is of interest. In the APEX trial, post-PCI TIMI flow assessment by the ACL provided better prediction than Op assessment for 90-day death. 10 In the present study, both Op and ACL assessment of post-PCI TIMI 3 (versus 0 to 2) flow were strongly predictive of 3-year mortality, with identical adjusted hazard ratios of 0.49. Furthermore, it is notable when Op and ACL were discordant for post-PCI TIMI flow, 3-year mortality rates were intermediate compared with when both recorded TIMI 0 to 2 or TIMI 3 flow, with ACL TIMI 0 to 2/Op TIMI 3 being only slightly more predictive than Op TIMI 0 to 2/ACL TIMI 3. A similar pattern was noted for post-PCI MBG, with Op/ACL discordant post-PCI MBG predicting comparable and relatively low mortality rates. Given the fact that both post-PCI TIMI 3 flow and MBG 2 to 3 have been strongly associated with survival when assessed by an ACL, [22] [23] [24] these data suggest that Op do incorporate other (nonangiographic) elements of the patient's clinical condition into their assessment.
When interpreting the results of this study, it is important to realize that repeated assessments in the same ACL or comparisons between different ACL assessments yield less than perfect correlations. For example, Steigen et al 12 showed that, among 5 quantitative and 6 qualitative parameters reviewed by 2 different ACL, there was excellent agreement for minimal lumen diameter and ejection fraction, while reproducibility for MBG and thrombus grade was only moderate. The same was true for intralaboratory variability. In contrast, the ACL used in the present study has reported high intraobserver and interobserver technician reproducibility for MBG at 2 different time periods. 25, 26 Several limitations of the present analysis need to be addressed. First, while κ for MBG was quite low, post-PCI Op MBG predicted survival quite well and comparable to ACL data. This is likely due to the fact that MBG 2 to 3 was common after PCI, and operators were able to detect >90% of those cases correctly. Second, the results of the present study should not be taken as evidence that measures directed at improving suboptimal TIMI flow or MBG (either pre-PCI or post-PCI) result in improved survival. Indeed, efforts to improve survival by enhancing pre-PCI TIMI flow with fibrinolysis were counterproductive. 27 Third, there may have been greater variability between ACL and Op had both TIMI flow and MBG been assessed as 3 or 4 groups, rather than binary TIMI 0 to 2 versus 3, and MBG 0 to 1 versus 2 to 3. Moreover, the codes for TIMI flow and MBG were not equiprobable, as there was a substantial preponderance of pre-PCI TIMI flow 0 to 2 and MBG 0 to 1 (rather than TIMI 3 and MBG 2 to 3), and of post-PCI TIMI flow 3 and MBG 2 to 3 (rather than TIMI flow 0 to 2 and MBG 0 to 1). In this regard, κ levels tend to be higher (greater concordance) when there are more codes that are equiprobable and when there is similar distribution of the codes among the readers. 28 For example, in one simulation, κ varied from 0.49 for 2 codes to 0.69 for 10 codes for observers who were 85% accurate. 29 These considerations notwithstanding, we conclude that the present prespecified analysis in 3345 patients undergoing primary PCI from the HORIZONS-AMI trial demonstrates that the concordance between Op and ACL assessment of angiographic markers of reperfusion in STEMI is only fair to moderate and that there is directionality in these disagreements, with the Op underestimating favorable findings pre-PCI and overestimating their rate post-PCI. Because primary PCI is successful in most patients, the impact of this variability is relatively minor in terms of mortality prediction. Further study is warranted to determine the extent to which Op incorporate nonangiographic assessment of the patient condition into their angiographic evaluations and whether active interventions to improve baseline or post-PCI TIMI flow and MBG improve survival. Nevertheless, further Op training to reduce between Op and ACL variability are likely to improve reliability of site-reported results in clinical investigation and practice and contribute to Op's ability to identify when optimal reperfusion is achieved. Op indicates operator; ACL, angiographic core laboratory; TIMI denotes Thrombolysis in Myocardial Infarction flow; MBG denotes densitometric myocardial blush grade; CI, confidence interval.
